Matinas BioPharma Holdings (MTNB) Dividends payables (2017 - 2019)
Matinas BioPharma Holdings (MTNB) posted quarterly Dividends payables of $600000.0 for Q4 2019, down 48.91% year-over-year from $1.2 million in Q4 2018, and little changed quarter-over-quarter from $600000.0 in Q3 2019.
Matinas BioPharma Holdings (MTNB) Dividends payables (2017 - 2019) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Dividends payables for 3 consecutive years, with $600000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Dividends payables fell 48.91% year-over-year to $600000.0; the TTM figure through Dec 2019 stood at $600000.0 (down 48.91% YoY), while the FY2019 annual figure was $600000.0, down 48.91% from the prior year.
- Dividends payables held at $600000.0 in Q4 2019 per MTNB's latest filing, from $600000.0 in the prior quarter.
- Across five years, Dividends payables topped out at $1.2 million in Q3 2018 and bottomed at $600.0 in Q1 2018.
- Historically, Dividends payables has averaged $812218.0 across 3 years, with a median of $887143.0 in 2017.
- On a YoY basis, Dividends payables climbed as much as 195614.33% in 2019 and fell as far as 48.91% in 2019.
- Matinas BioPharma Holdings' Dividends payables stood at $600000.0 in 2017, then jumped by 95.71% to $1.2 million in 2018, then sank by 48.91% to $600000.0 in 2019.
- Business Quant data shows MTNB's Dividends payables at $600000.0 in Q4 2019, $600000.0 in Q3 2019, and $1.2 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 1.17 Mn |
| Mar 31, 2019 | 1.17 Mn |
| Dec 31, 2018 | 1.17 Mn |
| Sep 30, 2018 | 1.17 Mn |
| Mar 31, 2018 | 600.00 |
| Dec 31, 2017 | 600,000.00 |